Milestone Scientific Inc. (MLSS)
NYSEAMERICAN: MLSS · Real-Time Price · USD
0.3029
-0.0071 (-2.29%)
Nov 26, 2025, 4:00 PM EST - Market closed
Milestone Scientific Market Cap
Milestone Scientific has a market cap or net worth of $23.82 million as of November 26, 2025. Its market cap has decreased by -55.98% in one year.
Market Cap
23.82M
Enterprise Value
23.53M
1-Year Change
-55.98%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since December 1, 1998, Milestone Scientific's market cap has increased from $9.90M to $23.82M, an increase of 140.57%. That is a compound annual growth rate of 3.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 23.80M | -68.18% |
| Dec 31, 2024 | 74.80M | 52.65% |
| Dec 29, 2023 | 49.00M | 46.27% |
| Dec 30, 2022 | 33.50M | -76.04% |
| Dec 31, 2021 | 139.80M | 3.56% |
| Dec 31, 2020 | 135.00M | 98.82% |
| Dec 31, 2019 | 67.90M | 506.25% |
| Dec 31, 2018 | 11.20M | -71.28% |
| Dec 29, 2017 | 39.00M | -0.76% |
| Dec 30, 2016 | 39.30M | -22.18% |
| Dec 31, 2015 | 50.50M | 3.27% |
| Dec 31, 2014 | 48.90M | 63.55% |
| Dec 31, 2013 | 29.90M | 32.30% |
| Dec 31, 2012 | 22.60M | 303.57% |
| Dec 30, 2011 | 5.60M | -63.16% |
| Dec 31, 2010 | 15.20M | -41.09% |
| Dec 31, 2009 | 25.80M | 637.14% |
| Dec 31, 2008 | 3.50M | -82.50% |
| Dec 31, 2007 | 20.00M | 47.06% |
| Dec 29, 2006 | 13.60M | -15.00% |
| Dec 30, 2005 | 16.00M | -7.51% |
| Dec 31, 2004 | 17.30M | -7.98% |
| Dec 31, 2003 | 18.80M | 394.74% |
| Dec 31, 2002 | 3.80M | -38.71% |
| Dec 31, 2001 | 6.20M | -55.71% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.20B |
| Johnson & Johnson | 496.44B |
| AbbVie | 405.63B |
| UnitedHealth Group | 289.01B |
| AstraZeneca | 283.06B |
| Merck & Co. | 249.20B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 221.17B |